🔗 Share this article

As America continues making unprecedented revisions to its immunization guidelines, one figure has emerged in a surprising turn: Dr. Tracy Beth Høeg, an American of Danish descent sports medicine doctor and epidemiologist who first made her name by expressing skepticism about coronavirus vaccines in the pandemic and has focused upon possible fatalities after Covid immunization in her recent position at the Food and Drug Administration.

Scheduled Changes to Pediatric Vaccine Program

Agency leaders had intended to unveil major revisions to the pediatric vaccination calendar recently, bringing the US with Denmark’s national calendar, it is understood – a substantial departure that would put the US out of step with much of the international standard with little proof for public health gain. The planned update has been pushed back until the coming year.

Instead of the director of the vaccine center, Høeg is set to speak at the meeting. She was just designated interim head of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth person to lead the office this year.

A Shift at the FDA

Høeg's temporary position could signify a strengthened alliance between the drug and vaccine divisions as Høeg and Prasad solidify control at the agency – and it suggests a greater focus upon rolling back already-approved immunizations at the FDA.

Høeg has repeatedly called for discontinuing certain pediatric shot schedules in the US in order to be more similar to Denmark, a society with universal health coverage and a population about the size of Wisconsin’s.

So far comments, she has kept her attention on immunizations – traditionally the purview of Prasad, director of the FDA’s vaccine center – rather than medication approval.

Concerns Over Expertise

The appointee has no apparent track record in pharmaceutical research, oversight or leadership, which has been customary for past leaders of the Center for Biologics Evaluation and Research. She has been employed at the FDA as a senior adviser to the agency head and CBER since earlier this year.

“It seems she lacks to have the requisite experience” for leading the CDER, stated Dr. Jonathan Howard. “She’s never run a scientific study. She lacks experience in managing a major agency. She has no expertise in industry regulation.”

Previous commissioners of the center would “be deeply familiar with legal statutes and the research of drug development”, commented Janet Woodcock. “Clearly, she has not acquired the sort of resume that prior appointees who headed the center have had.”

CDER has an immense range of responsibilities at the FDA, the former commissioner emphasized.

“The public just pays attention on the novel medication approvals, but the generic drug division authorizes a multitude of generic drugs. There’s a biosimilars program, non-prescription drug unit and so forth, and all of those have to be supervised,” Woodcock explained. “The responsibility you overlook, that is precisely what that I always told people is going to come back to haunt you.”

There is also, a significant leadership element to the role, which manages more than 5,000 staff members. “It is a huge management job, if you do it right,” the former official concluded.

Official Statement and Contentious Programs

In response to questions about Høeg’s credentials and whether this selection indicates greater collaboration among regulatory chiefs on vaccines, a press secretary stated that the “inquiries stem from flawed assumptions”.

“This background aligns with the responsibilities of her job,” the spokesperson said, noting the period Høeg spent counseling the agency head on “medication safety and oversight research, including computerized risk analysis and vaccine surveillance”.

As acting director, Dr. Høeg inherits the commissioner’s recently launched expedited review system, a contentious rapid drug-approval program that apparently concerned her predecessors. “By what process are these drugs being selected for this expedited pathway? Who takes the decisions?” Dr. Howard questioned. “There is a lot of secrecy going on at the regulatory body right now.”

In general, he remarked, “the Food and Drug Administration appears to be shifting towards less stringent regulations of all drugs, with the exception of vaccines.”

Established Track Record on Immunizations

With immunizations, Høeg has a more established, if problematic, past, Howard said. She published a analysis using unconfirmed crowd-sourced reports to estimate the frequency of heart inflammation following COVID-19 immunization. She counseled the state of Florida top health official Joseph Ladapo, who reportedly have modified findings to suggest COVID-19 vaccines are more dangerous than they are.

Included in her “desired changes” for the incoming government included changing guidelines for novel immunizations and halting “non-essential” vaccines, she remarked after the election on a audio program. At the agency, Høeg has according to sources proposed excluding teenage boys from receiving Covid vaccinations.

“She is an all-around true believer who starts off with her preconceived notions and tailors the evidence to accommodate the evidence in a very disingenuous, dishonest fashion,” Dr. Howard argued.

Consolidating Power and a “Revenge Tour”

Høeg joined other contrarians, {like|